Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
3.350
-0.009 (-0.27%)
At close: Oct 27, 2026, 4:00 PM EDT
3.400
+0.050 (1.49%)
After-hours: Oct 27, 2026, 6:26 PM EDT
Passage Bio Employees
Passage Bio had 24 employees as of December 31, 2025. The number of employees decreased by 36 or 60.00% compared to the previous year. That makes Passage Bio the 37,844th largest employer in the world and 5,394th in the United States.
Employees
24
Change (1Y)
-36
Growth (1Y)
-60.00%
Revenue / Employee
n/a
Profits / Employee
-$1,504,667
Market Cap
10.78M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 24 | -36 | -60.00% |
| Dec 31, 2024 | 60 | 2 | 3.45% |
| Dec 31, 2023 | 58 | -27 | -31.76% |
| Dec 31, 2022 | 85 | -48 | -36.09% |
| Dec 31, 2021 | 133 | 59 | 79.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Karyopharm Therapeutics | 228 |
| CytoMed Therapeutics | 42 |
| Radiopharm Theranostics | 14 |
| BioVie | 13 |
| Psyence Biomedical | 12 |
| Tvardi Therapeutics | 12 |
| Cellectar Biosciences | 11 |
| Purple Biotech | 10 |
PASG News
- 2 months ago - Passage Bio Quarterly report: Q2 2026 - Filings
- 3 months ago - Passage Bio Slides: Investor presentation - Filings
- 4 months ago - Passage Bio trading resumes - TheFly
- 4 months ago - Passage Bio Transcript: M&A announcement - Transcripts
- 4 months ago - Passage Bio Press release: M&A announcement - Filings
- 4 months ago - Passage Bio, Remix Therapeutics to combine in all-stock transaction - TheFly
- 4 months ago - Passage Bio trading halted, news pending - TheFly
- 4 months ago - Passage Bio and Remix Therapeutics Announce Merger Agreement - GlobeNewsWire